Company Filing History:
Years Active: 2022
Title: Katharina Asmus: Innovator in Pharmaceutical Compositions
Introduction
Katharina Asmus is a notable inventor based in Neustadt a.d.W., Germany. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of Hepatitis C Virus (HCV). Her innovative work has led to the development of a unique solid pharmaceutical composition that showcases her expertise and dedication to improving healthcare.
Latest Patents
Katharina Asmus holds one patent titled "Solid pharmaceutical compositions for treating HCV." This invention features solid pharmaceutical compositions that comprise Compound 1 and Compound 2. In one embodiment, the solid pharmaceutical composition includes a first layer comprising 100 mg of Compound 1, along with a pharmaceutically acceptable hydrophilic polymer and a pharmaceutically acceptable surfactant, all formulated in amorphous solid dispersion. Additionally, a second layer comprises 40 mg of Compound 2, also formulated with a hydrophilic polymer and surfactant in amorphous solid dispersion.
Career Highlights
Katharina Asmus is currently associated with AbbVie Inc., a leading global biopharmaceutical company. Her work at AbbVie has allowed her to focus on innovative solutions for complex health issues, particularly in the realm of viral infections. Her contributions have been instrumental in advancing pharmaceutical research and development.
Collaborations
Throughout her career, Katharina has collaborated with esteemed colleagues, including Nancy E Sever and Ulrich Westedt. These collaborations have fostered a productive environment for innovation and have contributed to the success of her projects.
Conclusion
Katharina Asmus is a remarkable inventor whose work in pharmaceutical compositions has the potential to make a significant impact on the treatment of HCV. Her dedication to innovation and collaboration exemplifies the spirit of advancement in the pharmaceutical industry.